TREM2 and prostate cancer: In advanced and castration resistant prostate cancer, spatial transcriptomics and imaging mass spectrometry flow cytometry showed co localization of TREM2 +/SPP1 + TAM with hypoxic and lipid rich tumor regions, adjacent blood vessels, and specific CAF subgroups (14).